- Lazard recently reported first-quarter results showing year-on-year revenue growth but falling short of analyst expectations, while emphasizing its acquisition of Campbell Lutyens as a step toward building a more productive, growth-oriented firm.
- Alongside these mixed earnings, Lazard confirmed a June 2026 distribution from its Global Total Return and Income Fund and outlined upcoming investor outreach, offering a broader view of how it is positioning both its advisory and asset management franchises.
- We’ll now examine how Lazard’s earnings miss, despite revenue growth, may influence the existing investment narrative built around expansion-driven costs.
Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Lazard Investment Narrative Recap
To own Lazard, you need to believe that its mix of financial advisory and asset management can justify ongoing investment in expansion and talent, even as past revenue growth and earnings per share have been sluggish. The latest quarter’s revenue growth but earnings miss, and the stock’s pullback, reinforce the near term risk that higher costs outpace revenue, while the key catalyst remains whether recent hires and acquisitions start to support margins more visibly. So far, this news does not materially change that balance.
The announcement most tied to this story is the planned June 10 fireside discussion with CEO Peter Orszag at the Morgan Stanley U.S. Financials Conference. Coming so soon after a quarter that disappointed relative to expectations, this event gives Lazard an opportunity to clarify how acquisitions like Campbell Lutyens and elevated operating expenses fit into its broader plan for its advisory and asset management franchises, and how management is thinking about near term profitability pressures.
Yet behind Lazard’s expansion push, investors should also be aware of the risk that rising compensation and operating costs could keep net margins under pressure while...
Read the full narrative on Lazard (it's free!)
Lazard's narrative projects $4.6 billion revenue and $522.4 million earnings by 2029. This requires 12.9% yearly revenue growth and about a $250.9 million earnings increase from $271.5 million today.
Uncover how Lazard's forecasts yield a $52.38 fair value, a 9% upside to its current price.
Exploring Other Perspectives
Before this quarter, the most pessimistic analysts were already cautious, assuming revenue of about US$4.1 billion and earnings near US$687.0 million by 2028, and their view highlights how sharply opinions can diverge from the more optimistic story of expanding advisory capabilities that depends on expensive senior talent staying productive and well aligned with shareholder returns.
Explore 4 other fair value estimates on Lazard - why the stock might be worth just $52.38!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Lazard research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Lazard research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lazard's overall financial health at a glance.
Searching For A Fresh Perspective?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com